Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

计划入组 267 人 · 首次发布于 2024 年 5 月 16 日

Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

计划入组 588 人 · 首次发布于 2017 年 6 月 23 日

A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

计划入组 360 人 · 首次发布于 2017 年 12 月 12 日

H7N9 vaccine(Instituto Butantan)

H7N9 monovalent vaccine

Influenza A virus H7N9 vaccine (Seqirus)

AIM VACCINE

China

Finlay Vaccine Institute

Path Vaccine Solutions

United States

Vaxxas Initiates Phase I Trial of H7N9 Avian Influenza Vaccine Delivered via HD-MAP

Vaxxas Advances Novel Microneedle Patch Delivery for H7N9 Bird Flu Vaccine in Phase I Trial

Moderna Secures $590 Million HHS Award to Advance mRNA-Based Influenza Vaccine Development